Last reviewed · How we verify

NCT04522934

A Pilot Randomized Trial of Pain Neuroscience Education in the Rehabilitation After Arthroscopic Rotator Cuff Repair

Completed NA Last updated 21 August 2020
What this trial tests

NA trial testing Pain Neuroscience Education in Rotator Cuff Injuries in 29 participants. Completed in 25 January 2019.

Timeline
26 February 2018
Primary endpoint
25 January 2019
25 January 2019

Quick facts

Lead sponsorUniversidad Católica del Maule
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment29
Start date26 February 2018
Primary completion25 January 2019
Estimated completion25 January 2019
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica del Maule

Who can join

Adults 30 to 60, any sex, with Rotator Cuff Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the effects of a 8-week pain neuroscience education programme compared to a biomedical education programme on the rehabilitation of patients who undergo arthroscopic rotator cuff repair. Outcome measures included pain intensity, patients' attitudes and beliefs about pain, disability and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pain Neuroscience Education

Trials testing the same drug.

Other recruiting trials for Rotator Cuff Injuries

Currently open trials in the same condition.

Other Universidad Católica del Maule trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04522934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing